4//SEC Filing
Schiller Brigitte 4
Accession 0001213900-22-052329
CIK 0001766140other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 5:01 PM ET
Size
7.4 KB
Accession
0001213900-22-052329
Insider Transaction Report
Form 4
Schiller Brigitte
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-07-15−26,738→ 0 total→ Common Stock (26,738 underlying) - Exercise/Conversion
Common Stock
2022-07-15+26,738→ 26,738 total
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022.
- [F2]Each restricted stock unit is the economic equivalent of one share of Unicycive Therapeutics common stock.
- [F3]On July 15, 2021, the reporting person was granted 26,738 restricted stock units, all of which vested on July 15, 2022. The common stock into which such vested restricted stock units converted on July 15, 2022 is reported in Table I on this Form 4.
Documents
Issuer
Unicycive Therapeutics, Inc.
CIK 0001766140
Entity typeother
Related Parties
1- filerCIK 0001858938
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 5:01 PM ET
- Size
- 7.4 KB